Oxford-Harrington Rare Disease Centre Bio Tech Profile Feature in PharmaSource
“We embed industry expertise directly into academia through our Scholar Award program, which provides a miniâbiotech/pharma team to each OxfordâHarrington Scholar we support,” says Matthew Anderson, CoâDirector of the OxfordâHarrington Rare Disease Centre. Each Scholar receives drug development, commercial strategy, and business development support—an approach designed... Continue Reading